43 min Jan 21, 2021
What are nanomedicines? And how are they different from traditional ones?
In this episode of Science on surfaces we talk to Dr. Gustav Emilsson about the fascinating area of nanomedicines Dr. Emilsson is working as a Postdoc with nanomedicine development at the department of Advanced drug delivery in Pharmaceutical Science at AstraZeneca, a global, science-led biopharmaceutical company.
We start out by talking about what nanomedicines are and how they work. Dr. Emilsson explains how intricate design of these minuscule drug carriers can help overcome challenges such as drug toxicity and solubility issues, and how nanomedicines can be used to control the drug release in the body. We also talk about a phenomenon that is very relevant in the context of nanomedicines - the formation of the so-called protein corona, which affects how the drug delivery vessel interacts with the body. And finally, Dr. Emilsson shares some thoughts on what the future looks like for this intriguing area.
Thanks for listening! If you are interested in surface science and related topics, you should also check out our blog - the Surface Science blog.
53 min Jun 3, 2020
21 min May 20, 2020
20 min May 6, 2020
31 min Apr 22, 2020
23 min Apr 8, 2020
30 min Mar 25, 2020
33 min Mar 11, 2020
28 min Feb 25, 2020
50 min Feb 13, 2020
38 min Dec 18, 2019
47 min Dec 4, 2019
50 min Nov 21, 2019
42 min Nov 6, 2019
41 min Oct 24, 2019
48 min Oct 9, 2019
43 min Sep 23, 2019
32 min Aug 15, 2019